BioCryst Pharmaceuticals, Inc.

567 articles about BioCryst Pharmaceuticals, Inc.

• Biocryst Pharmaceuticals To Present At The UBS Global Specialty Pharmaceuticals Conference

  4/19/2006

• Biocryst Pharmaceuticals Announces Presentation Of Forodesine Hydrochloride Data During the 97th Annual Meeting Of The American Association for Cancer Research

  4/6/2006

• Biocryst Pharmaceuticals Initiates Intravenous Peramivir Phase I Clinical Trial

  3/9/2006

• Biocryst Pharmaceuticals To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006

  2/10/2006

• Biocryst Pharmaceuticals Reports Fourth Quarter And Year-End 2005 Financial Results

  2/8/2006

• Biocryst Pharmaceuticals To Release Fourth Quarter And Year-End 2005 Financial Results On Wednesday, February 8, 2006; Conference Call And Webcast To Follow

  2/3/2006

• Biocryst Pharmaceuticals To Present At The 2006 Merrill Lynch Global Pharmaceutical, Biotechnology And Medical Device Conference

  2/3/2006

• Biocryst Pharmaceuticals And Mundipharma International Limited Collaborate On Development Of Fodosine(TM)

  2/2/2006

• Biocryst Pharmaceuticals Gets Fast-Track For Flu Drug; Shares Rise

  1/17/2006

• Biocryst Pharmaceuticals Says FDA OKs Human Test Of Influenza Drug; Sending Shares Up

  12/22/2005

• Biocryst Pharmaceuticals Initiates Intravenous Phase I/II Clinical Trial Of Fodosine(TM) In Patients With B-Cell Acute Lymphoblastic Leukemia

  12/22/2005

• Biocryst Pharmaceuticals Announces Early Termination Of Hart-Scott-Rodino Waiting Period For The Roche License Of BCX-4208

  12/22/2005

• Biocryst Pharmaceuticals And Roche Licensing Deal Wins Early Approval From FTC

  12/22/2005

• Biocryst Pharmaceuticals Completes $30.0 Million Common Stock Offering To Institutional Investors

  12/19/2005

• Biocryst Pharmaceuticals Announces $30.0 Million Common Stock Offering To Institutional Investors

  12/15/2005

• Biocryst Pharmaceuticals Announces Presentation Of Fodosine(TM) Data During The 47th Annual Meeting And Exposition Of The American Society of Hematology

  12/12/2005

• Biocryst Pharmaceuticals To Provide Summary Of Data Presented At The 47th Annual Meeting And Exposition Of The American Society of Hematology

  12/7/2005

• Roche And Biocryst Pharmaceuticals Collaborate On Clinical Compound BCX-4208 For Transplantation And Autoimmune Diseases; Agreement Worth Up To $530 Million

  11/30/2005

• Biocryst Pharmaceuticals To Present At The Lazard Capital Markets Annual Life Sciences Conference

  11/28/2005

• Biocryst Pharmaceuticals Files IND Application For Injectable Peramivir

  11/28/2005